RocketTickers

Sage Therapeutics Receives Fast Track Designation for SAGE-718 f

Long
NASDAQ:SAGE   Sage Therapeutics, Inc.
SAGE: Sage Therapeutics, Inc.
2021-09-15 06:30:00
Sage Therapeutics Receives Fast Track Designation for SAGE-718 for the Treatment of Huntington’s Disease
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.